Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
Aberlyn, accurately, alleged, ASCO, Boehringer, cantuzumab, Carmichael, category, certainty, choose, Christie, Click, Committee, CompanyMitchel, compensatory, complaint, composed, concurrent, constrained, daily, declaratory, deferral, deny, District, documentUNITED, dosage, earlier, Enterprise, exceeded, extracellular, fire, gastric, GmbH, Herceptin, HuCAL, hurt, incidence, Index, inflow, Ingelheim, judged, launch, length, Lorigan, Malcolm, Manchester, margin, mertansine, microorganism, misleading, move, multidose, myeloid, navigate, neuroendocrine, nominal, nonexclusive, notified, Nottingham, oral, PageReport, paragraph, Penella, peritoneal, Pharmacia, portrayal, predicated, proceed, Professional, prolonged, Ranson, regime, relief, remedy, renegotiate, renegotiated, renegotiation, renovate, sabotage, safer, satisfaction, satisfactory, settle, settled, settling, Shire, solicitation, strain, strong, successor, Taxol, thereunder, transgenic, travel, unclear, undisclosed, unexpected, unfavorable, unknown, untrue, upfront, Upjohn, viability, Woll, write
Filing tables
Filing exhibits
IMGN similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
EXHIBIT 21
ImmunoGen Securities Corp., a Massachusetts corporation
Apoptosis Technology, Inc., a Massachusetts corporation
SUBSIDIARIES